nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaliplatin—MPO—saliva—attention deficit hyperactivity disorder	0.0369	0.0691	CbGeAlD
Oxaliplatin—MT2A—forebrain—attention deficit hyperactivity disorder	0.019	0.0355	CbGeAlD
Oxaliplatin—MT2A—cardiovascular system—attention deficit hyperactivity disorder	0.016	0.03	CbGeAlD
Oxaliplatin—GSTT1—cardiovascular system—attention deficit hyperactivity disorder	0.0157	0.0294	CbGeAlD
Oxaliplatin—ATP7A—cardiovascular system—attention deficit hyperactivity disorder	0.0139	0.026	CbGeAlD
Oxaliplatin—MT1A—cerebellum—attention deficit hyperactivity disorder	0.0116	0.0218	CbGeAlD
Oxaliplatin—GSTM1—cardiovascular system—attention deficit hyperactivity disorder	0.0116	0.0216	CbGeAlD
Oxaliplatin—ATP7B—nervous system—attention deficit hyperactivity disorder	0.0111	0.0207	CbGeAlD
Oxaliplatin—ATP7A—midbrain—attention deficit hyperactivity disorder	0.0108	0.0203	CbGeAlD
Oxaliplatin—ATP7B—central nervous system—attention deficit hyperactivity disorder	0.0107	0.02	CbGeAlD
Oxaliplatin—ATP7B—cerebellum—attention deficit hyperactivity disorder	0.0104	0.0195	CbGeAlD
Oxaliplatin—MT2A—nervous system—attention deficit hyperactivity disorder	0.0103	0.0193	CbGeAlD
Oxaliplatin—GSTT1—nervous system—attention deficit hyperactivity disorder	0.0101	0.0189	CbGeAlD
Oxaliplatin—MT2A—central nervous system—attention deficit hyperactivity disorder	0.00991	0.0186	CbGeAlD
Oxaliplatin—NQO1—forebrain—attention deficit hyperactivity disorder	0.00958	0.0179	CbGeAlD
Oxaliplatin—SOD1—midbrain—attention deficit hyperactivity disorder	0.00949	0.0178	CbGeAlD
Oxaliplatin—MT1A—brain—attention deficit hyperactivity disorder	0.00944	0.0177	CbGeAlD
Oxaliplatin—SLC31A1—midbrain—attention deficit hyperactivity disorder	0.00925	0.0173	CbGeAlD
Oxaliplatin—MPO—forebrain—attention deficit hyperactivity disorder	0.00881	0.0165	CbGeAlD
Oxaliplatin—GSTP1—forebrain—attention deficit hyperactivity disorder	0.00856	0.016	CbGeAlD
Oxaliplatin—ATP7B—brain—attention deficit hyperactivity disorder	0.00846	0.0158	CbGeAlD
Oxaliplatin—NQO1—cardiovascular system—attention deficit hyperactivity disorder	0.0081	0.0152	CbGeAlD
Oxaliplatin—MT2A—brain—attention deficit hyperactivity disorder	0.00787	0.0147	CbGeAlD
Oxaliplatin—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.00766	0.0143	CbGeAlD
Oxaliplatin—SLC31A1—nervous system—attention deficit hyperactivity disorder	0.0076	0.0142	CbGeAlD
Oxaliplatin—MPO—cardiovascular system—attention deficit hyperactivity disorder	0.00745	0.0139	CbGeAlD
Oxaliplatin—GSTM1—nervous system—attention deficit hyperactivity disorder	0.00742	0.0139	CbGeAlD
Oxaliplatin—SOD1—cerebellum—attention deficit hyperactivity disorder	0.00734	0.0137	CbGeAlD
Oxaliplatin—SLC31A1—central nervous system—attention deficit hyperactivity disorder	0.00732	0.0137	CbGeAlD
Oxaliplatin—GSTP1—cardiovascular system—attention deficit hyperactivity disorder	0.00724	0.0136	CbGeAlD
Oxaliplatin—SLC31A1—cerebellum—attention deficit hyperactivity disorder	0.00715	0.0134	CbGeAlD
Oxaliplatin—GSTM1—central nervous system—attention deficit hyperactivity disorder	0.00714	0.0134	CbGeAlD
Oxaliplatin—GSTM1—cerebellum—attention deficit hyperactivity disorder	0.00698	0.0131	CbGeAlD
Oxaliplatin—ATP7A—brain—attention deficit hyperactivity disorder	0.00681	0.0128	CbGeAlD
Oxaliplatin—CA4—forebrain—attention deficit hyperactivity disorder	0.00652	0.0122	CbGeAlD
Oxaliplatin—NQO1—midbrain—attention deficit hyperactivity disorder	0.00633	0.0118	CbGeAlD
Oxaliplatin—SOD1—brain—attention deficit hyperactivity disorder	0.00596	0.0112	CbGeAlD
Oxaliplatin—SLC31A1—brain—attention deficit hyperactivity disorder	0.00581	0.0109	CbGeAlD
Oxaliplatin—CYP1B1—cardiovascular system—attention deficit hyperactivity disorder	0.00569	0.0107	CbGeAlD
Oxaliplatin—GSTM1—brain—attention deficit hyperactivity disorder	0.00567	0.0106	CbGeAlD
Oxaliplatin—GSTP1—midbrain—attention deficit hyperactivity disorder	0.00565	0.0106	CbGeAlD
Oxaliplatin—CA4—cardiovascular system—attention deficit hyperactivity disorder	0.00552	0.0103	CbGeAlD
Oxaliplatin—NQO1—nervous system—attention deficit hyperactivity disorder	0.0052	0.00974	CbGeAlD
Oxaliplatin—NQO1—central nervous system—attention deficit hyperactivity disorder	0.00501	0.00937	CbGeAlD
Oxaliplatin—NQO1—cerebellum—attention deficit hyperactivity disorder	0.00489	0.00916	CbGeAlD
Oxaliplatin—MPO—nervous system—attention deficit hyperactivity disorder	0.00478	0.00895	CbGeAlD
Oxaliplatin—GSTP1—nervous system—attention deficit hyperactivity disorder	0.00465	0.0087	CbGeAlD
Oxaliplatin—MPO—central nervous system—attention deficit hyperactivity disorder	0.0046	0.00862	CbGeAlD
Oxaliplatin—GSTP1—central nervous system—attention deficit hyperactivity disorder	0.00447	0.00838	CbGeAlD
Oxaliplatin—GSTP1—cerebellum—attention deficit hyperactivity disorder	0.00437	0.00819	CbGeAlD
Oxaliplatin—CA4—midbrain—attention deficit hyperactivity disorder	0.00431	0.00807	CbGeAlD
Oxaliplatin—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.00416	0.00778	CbGeAlD
Oxaliplatin—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.004	0.00749	CbGeAlD
Oxaliplatin—NQO1—brain—attention deficit hyperactivity disorder	0.00397	0.00744	CbGeAlD
Oxaliplatin—SLC22A3—nervous system—attention deficit hyperactivity disorder	0.00397	0.00744	CbGeAlD
Oxaliplatin—SLC22A3—central nervous system—attention deficit hyperactivity disorder	0.00383	0.00716	CbGeAlD
Oxaliplatin—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.00367	0.00687	CbGeAlD
Oxaliplatin—MPO—brain—attention deficit hyperactivity disorder	0.00365	0.00684	CbGeAlD
Oxaliplatin—CYP1B1—nervous system—attention deficit hyperactivity disorder	0.00365	0.00684	CbGeAlD
Oxaliplatin—GSTP1—brain—attention deficit hyperactivity disorder	0.00355	0.00665	CbGeAlD
Oxaliplatin—CA4—nervous system—attention deficit hyperactivity disorder	0.00354	0.00663	CbGeAlD
Oxaliplatin—CYP1B1—central nervous system—attention deficit hyperactivity disorder	0.00352	0.00658	CbGeAlD
Oxaliplatin—CYP1B1—cerebellum—attention deficit hyperactivity disorder	0.00344	0.00643	CbGeAlD
Oxaliplatin—CA4—central nervous system—attention deficit hyperactivity disorder	0.00341	0.00638	CbGeAlD
Oxaliplatin—CA4—cerebellum—attention deficit hyperactivity disorder	0.00333	0.00624	CbGeAlD
Oxaliplatin—ABCG2—midbrain—attention deficit hyperactivity disorder	0.00331	0.00619	CbGeAlD
Oxaliplatin—SLC22A1—brain—attention deficit hyperactivity disorder	0.00318	0.00595	CbGeAlD
Oxaliplatin—SLC22A3—brain—attention deficit hyperactivity disorder	0.00304	0.00569	CbGeAlD
Oxaliplatin—CYP1B1—brain—attention deficit hyperactivity disorder	0.00279	0.00523	CbGeAlD
Oxaliplatin—CA4—brain—attention deficit hyperactivity disorder	0.00271	0.00507	CbGeAlD
Oxaliplatin—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.00258	0.00483	CbGeAlD
Oxaliplatin—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.00256	0.00479	CbGeAlD
Oxaliplatin—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.00249	0.00465	CbGeAlD
Oxaliplatin—NQO1—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00244	0.00523	CbGpPWpGaD
Oxaliplatin—SOD1—FOXA1 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00243	0.00522	CbGpPWpGaD
Oxaliplatin—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.00235	0.00441	CbGeAlD
Oxaliplatin—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.00227	0.00424	CbGeAlD
Oxaliplatin—GSTP1—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00223	0.00479	CbGpPWpGaD
Oxaliplatin—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.00222	0.00415	CbGeAlD
Oxaliplatin—NQO1—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00217	0.00467	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.00215	0.00462	CbGpPWpGaD
Oxaliplatin—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00208	0.00446	CbGpPWpGaD
Oxaliplatin—ABCG2—brain—attention deficit hyperactivity disorder	0.00208	0.00389	CbGeAlD
Oxaliplatin—SLC22A1—Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.002	0.0043	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.002	0.0043	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.002	0.00429	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.002	0.00429	CbGpPWpGaD
Oxaliplatin—CYP1A1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00198	0.00425	CbGpPWpGaD
Oxaliplatin—CYP1A1—brain—attention deficit hyperactivity disorder	0.00197	0.00369	CbGeAlD
Oxaliplatin—SOD1—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00196	0.00421	CbGpPWpGaD
Oxaliplatin—GSTM1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00196	0.0042	CbGpPWpGaD
Oxaliplatin—GSTM1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00194	0.00417	CbGpPWpGaD
Oxaliplatin—GSTM1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00193	0.00414	CbGpPWpGaD
Oxaliplatin—CYP1A1—Oxidative Stress—MAOA—attention deficit hyperactivity disorder	0.00193	0.00413	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00192	0.00413	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00189	0.00406	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00187	0.00401	CbGpPWpGaD
Oxaliplatin—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00186	0.00399	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—STUB1—attention deficit hyperactivity disorder	0.00183	0.00393	CbGpPWpGaD
Oxaliplatin—SOD1—Validated nuclear estrogen receptor alpha network—EP300—attention deficit hyperactivity disorder	0.0018	0.00387	CbGpPWpGaD
Oxaliplatin—CYP2E1—brain—attention deficit hyperactivity disorder	0.0018	0.00337	CbGeAlD
Oxaliplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—EP300—attention deficit hyperactivity disorder	0.00176	0.00377	CbGpPWpGaD
Oxaliplatin—SLC22A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0017	0.00366	CbGpPWpGaD
Oxaliplatin—GSTP1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00166	0.00357	CbGpPWpGaD
Oxaliplatin—GSTP1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00165	0.00355	CbGpPWpGaD
Oxaliplatin—GSTP1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00164	0.00352	CbGpPWpGaD
Oxaliplatin—ATP7B—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.0016	0.00343	CbGpPWpGaD
Oxaliplatin—SLC22A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00159	0.00341	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00154	0.0033	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.00149	0.00319	CbGpPWpGaD
Oxaliplatin—CYP1B1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00146	0.00312	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00143	0.00307	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—POLR3A—attention deficit hyperactivity disorder	0.00139	0.00298	CbGpPWpGaD
Oxaliplatin—SLC22A3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00138	0.00296	CbGpPWpGaD
Oxaliplatin—ATP7A—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00136	0.00292	CbGpPWpGaD
Oxaliplatin—SLC22A3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00132	0.00283	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.0013	0.0028	CbGpPWpGaD
Oxaliplatin—SLC31A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.0013	0.0028	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.00127	0.00272	CbGpPWpGaD
Oxaliplatin—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00126	0.00271	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00124	0.00266	CbGpPWpGaD
Oxaliplatin—ABCC2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00123	0.00263	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00122	0.00261	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-2-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00111	0.00239	CbGpPWpGaD
Oxaliplatin—ABCC2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00109	0.00234	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00103	0.0022	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00101	0.00217	CbGpPWpGaD
Oxaliplatin—ABCC2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00101	0.00216	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	0.000964	0.00207	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000959	0.00206	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000959	0.00206	CbGpPWpGaD
Oxaliplatin—ABCC2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000959	0.00206	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000956	0.00205	CbGpPWpGaD
Oxaliplatin—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000951	0.00204	CbGpPWpGaD
Oxaliplatin—SLC22A3—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000945	0.00203	CbGpPWpGaD
Oxaliplatin—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000897	0.00192	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000882	0.00189	CbGpPWpGaD
Oxaliplatin—ABCG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000874	0.00188	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000865	0.00186	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000857	0.00184	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000857	0.00184	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000843	0.00181	CbGpPWpGaD
Oxaliplatin—ABCG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000834	0.00179	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000826	0.00177	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000822	0.00176	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00082	0.00176	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000807	0.00173	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.0008	0.00172	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000786	0.00169	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000784	0.00168	CbGpPWpGaD
Oxaliplatin—CYP1B1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000779	0.00167	CbGpPWpGaD
Oxaliplatin—CYP1B1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000773	0.00166	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000769	0.00165	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000768	0.00165	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000764	0.00164	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000733	0.00157	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000731	0.00157	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00071	0.00152	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000685	0.00147	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000681	0.00146	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00068	0.00146	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000676	0.00145	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000663	0.00142	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000654	0.0014	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000652	0.0014	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00063	0.00135	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000628	0.00135	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000622	0.00133	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000617	0.00132	CbGpPWpGaD
Oxaliplatin—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000593	0.00127	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000591	0.00127	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000591	0.00127	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000586	0.00126	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	0.00058	0.00125	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000579	0.00124	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000575	0.00123	CbGpPWpGaD
Oxaliplatin—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000572	0.00123	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00056	0.0012	CbGpPWpGaD
Oxaliplatin—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000552	0.00119	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000552	0.00119	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000552	0.00119	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000543	0.00117	CbGpPWpGaD
Oxaliplatin—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.000523	0.00112	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000522	0.00112	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000519	0.00111	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000516	0.00111	CbGpPWpGaD
Oxaliplatin—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000509	0.00109	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	0.000506	0.00109	CbGpPWpGaD
Oxaliplatin—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000505	0.00108	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000505	0.00108	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000502	0.00108	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00049	0.00105	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00049	0.00105	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000482	0.00103	CbGpPWpGaD
Oxaliplatin—SLC22A3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00048	0.00103	CbGpPWpGaD
Oxaliplatin—CYP1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00048	0.00103	CbGpPWpGaD
Oxaliplatin—CYP1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000476	0.00102	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000476	0.00102	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000473	0.00102	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000473	0.00101	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00047	0.00101	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00047	0.00101	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000462	0.000991	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000458	0.000982	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000458	0.000982	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000457	0.000981	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00045	0.000966	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000448	0.000961	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000444	0.000953	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000441	0.000948	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000441	0.000946	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000429	0.000922	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00042	0.000902	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000419	0.000898	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000392	0.00084	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000377	0.000808	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000377	0.000808	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000375	0.000806	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000373	0.0008	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000366	0.000785	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000357	0.000767	CbGpPWpGaD
Oxaliplatin—ABCC2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00035	0.000751	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000348	0.000747	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000345	0.00074	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000335	0.000718	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000332	0.000713	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000319	0.000684	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000316	0.000677	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000316	0.000677	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00031	0.000666	CbGpPWpGaD
Oxaliplatin—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000306	0.000656	CbGpPWpGaD
Oxaliplatin—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000304	0.000653	CbGpPWpGaD
Oxaliplatin—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000304	0.000652	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000302	0.000647	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000301	0.000646	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000297	0.000637	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000295	0.000632	CbGpPWpGaD
Oxaliplatin—CYP1A1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000294	0.000631	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00029	0.000622	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000289	0.00062	CbGpPWpGaD
Oxaliplatin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000288	0.000618	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000287	0.000615	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000284	0.000611	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000282	0.000606	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—EP300—attention deficit hyperactivity disorder	0.000282	0.000606	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000281	0.000602	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000277	0.000595	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000275	0.000591	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000267	0.000574	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000252	0.000542	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00024	0.000516	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000223	0.000478	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00022	0.000472	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00022	0.000472	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000216	0.000464	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000208	0.000447	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000201	0.000432	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.0002	0.000429	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.0002	0.000429	CbGpPWpGaD
Oxaliplatin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000198	0.000426	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000198	0.000425	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000198	0.000425	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000197	0.000422	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000196	0.000421	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000195	0.000418	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000191	0.00041	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00019	0.000407	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000184	0.000396	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000184	0.000396	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000183	0.000393	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000182	0.00039	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000181	0.000389	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000176	0.000377	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000169	0.000362	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000167	0.000359	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00016	0.000343	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000158	0.00034	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000152	0.000327	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000151	0.000323	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000147	0.000317	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000144	0.000308	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000144	0.000308	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000143	0.000308	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000141	0.000303	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00014	0.000301	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000135	0.000291	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000135	0.000291	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000133	0.000286	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000133	0.000286	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000132	0.000284	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000131	0.000282	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000128	0.000275	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—EP300—attention deficit hyperactivity disorder	0.000127	0.000273	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000125	0.000268	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000124	0.000266	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000122	0.000262	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000121	0.00026	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00012	0.000258	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.00012	0.000257	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000119	0.000256	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000119	0.000255	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000115	0.000246	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000112	0.00024	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000111	0.000238	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000109	0.000235	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000108	0.000232	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000103	0.000221	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	8.7e-05	0.000187	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.64e-05	0.000185	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	8.63e-05	0.000185	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.63e-05	0.000185	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	8.49e-05	0.000182	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	8.2e-05	0.000176	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—EP300—attention deficit hyperactivity disorder	8.2e-05	0.000176	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.14e-05	0.000175	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.9e-05	0.00017	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.9e-05	0.000169	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.9e-05	0.000148	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.57e-05	0.000141	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—EP300—attention deficit hyperactivity disorder	5.71e-05	0.000123	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	5.23e-05	0.000112	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	5.2e-05	0.000112	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	5.19e-05	0.000111	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	5.14e-05	0.00011	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.04e-05	0.000108	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	4.79e-05	0.000103	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	3.73e-05	8.01e-05	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	3.52e-05	7.55e-05	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	2.24e-05	4.81e-05	CbGpPWpGaD
